Impact of the Addition of Metformin to Abiraterone in Pre-docetaxel Metastatic Castration-resistant Prostate Cancer Patients Progressing on Abiraterone Treatment (MetAb-Pro): a Phase II Pilot Study
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Abiraterone acetate (Primary) ; Metformin (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms METAB-PRO
- 12 Sep 2017 Status changed from recruiting to completed, as per an abstract presented at the 42nd European Society for Medical Oncology Congress
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress
- 09 Sep 2014 ClinicalTrials.gov record states the change of patient population from "post-docetaxel" to "pre-docetaxel" metastatic castration-resistant prostate cancer patients, it is reflected in the official title also.